FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

2213711000001102: Adgyn Medro 5mg tablets (Strakan Ltd) 14 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25281501000001114 Adgyn Medro 5mg tablets (Strakan Ltd) 14 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
100632701000001118 Adgyn Medro 5mg tablets (Kyowa Kirin Ltd) 14 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Adgyn Medro 5mg tablets (Strakan Ltd) 14 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Adgyn Medro 5mg tablets (Strakan Ltd) 14 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Adgyn Medro 5mg tablets (Strakan Ltd) 14 tablet Is a Medroxyprogesterone 5mg tablets 14 tablet true Inferred relationship Existential restriction modifier
Adgyn Medro 5mg tablets (Strakan Ltd) 14 tablet Is pack of Adgyn Medro 5mg tablets (Strakan Ltd) false Inferred relationship Existential restriction modifier
Adgyn Medro 5mg tablets (Strakan Ltd) 14 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Adgyn Medro 5mg tablets (Strakan Ltd) 14 tablet Has active ingredient Progesterone false Inferred relationship Existential restriction modifier
Adgyn Medro 5mg tablets (Strakan Ltd) 14 tablet Has active ingredient Medroxyprogesterone acetate false Inferred relationship Existential restriction modifier
Adgyn Medro 5mg tablets (Strakan Ltd) 14 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Adgyn Medro 5mg tablets (Strakan Ltd) 14 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Adgyn Medro 5mg tablets (Strakan Ltd) 14 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Adgyn Medro 5mg tablets (Strakan Ltd) 14 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Adgyn Medro 5mg tablets (Strakan Ltd) 14 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Adgyn Medro 5mg tablets (Strakan Ltd) 14 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Adgyn Medro 5mg tablets (Strakan Ltd) 14 tablet Has AMP Adgyn Medro 5mg tablets (Strakan Ltd) true Inferred relationship Existential restriction modifier
Adgyn Medro 5mg tablets (Strakan Ltd) 14 tablet Has specific active ingredient Medroxyprogesterone acetate true Inferred relationship Existential restriction modifier
Adgyn Medro 5mg tablets (Strakan Ltd) 14 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Adgyn Medro 5mg tablets (Strakan Ltd) 14 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start